Association between angiographic and clinical outcomes after STA-MCA bypass in adult moyamoya disease

Guicheng Kuang1, Hang Ji1, Jixuan Zheng2

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

European Stroke Journal
|September 11, 2024
PubMed
Abstract

Insights

Postoperative collateral formation (PCF) after STA-MCA bypass in moyamoya disease (MMD) reliably predicts clinical outcomes. Good PCF is linked to symptom improvement, while poor PCF correlates with recurrent cerebrovascular events.

Area of Science:

  • Neurosurgery
  • Vascular Surgery
  • Neurology

Background:

  • Moyamoya disease (MMD) management often involves STA-MCA bypass.
  • Postoperative collateral formation (PCF) is an angiographic outcome used to assess bypass efficacy.
  • The clinical relevance of PCF in MMD remains under investigation.

Purpose of the Study:

  • To investigate the association between PCF and clinical outcomes in adult patients with MMD.
  • To determine if PCF can serve as a reliable surrogate marker for clinical outcomes following STA-MCA bypass.

Main Methods:

  • Prospective cohort study of adult MMD patients undergoing STA-MCA bypass from 2013-2019.
  • Inclusion criteria: presurgical and follow-up catheter angiography.
  • Clinical outcomes assessed: symptom improvement and recurrent cerebrovascular events. Statistical analyses included logistic/Cox regression and Kaplan-Meier.

Main Results:

  • 165 hemispheres from 154 patients were analyzed; 63% had good PCF, 37% had poor PCF.
  • Good PCF was associated with younger age, higher incidence of hemodynamic dysfunction, and significantly higher symptom improvement (OR 28.96, p<0.001).
  • Poor PCF was linked to a higher incidence of recurrent cerebrovascular events (HR 3.77, p=0.014), with benefits observed in both hemorrhagic and ischemic onset hemispheres.

Conclusions:

  • Postoperative collateral formation (PCF) is a qualified surrogate marker for clinical outcomes in adult moyamoya disease patients after STA-MCA bypass.
  • Good PCF correlates with improved symptoms and reduced event rates, supporting its use in outcome assessment.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...